Why Stack GH Peptides?
The synergistic effect of combining GHRH analogues with GH secretagogues (GHRPs) produces GH pulses dramatically larger than either compound alone. Understanding this synergy requires knowing how the GH axis is regulated.
The GH Axis: A Two-Signal System
GH release from the pituitary is controlled by competing signals:
GHRH analogues (CJC-1295, Sermorelin) mimic GHRH's stimulatory signal. GHRPs (Ipamorelin, GHRP-2) both activate GHS-R1a receptors AND suppress somatostatin release.
Combining both creates synergy: increased stimulation + decreased inhibition = exponentially larger GH pulse.
The Top Stacking Protocols
Protocol 1: Ipamorelin + CJC-1295 No DAC
The Classic Clean Protocol
The most studied combination. Ipamorelin's selectivity (no cortisol/prolactin elevation) paired with CJC-1295 No DAC's pulsatile GHRH mimicry creates a natural-rhythm GH release.
Protocol 2: GHRP-2 + CJC-1295 No DAC
High Amplitude Protocol
GHRP-2 produces a larger GH pulse than Ipamorelin but with some cortisol elevation. Combined with CJC-1295 No DAC, this creates very high GH peaks.
Protocol 3: Ipamorelin + CJC-1295 With DAC
Long-Acting Protocol
CJC-1295 with DAC's 6-8 day half-life allows once or twice weekly administration of the GHRH component, combined with daily Ipamorelin. Provides sustained elevated GH throughout the week.
Research Use Only: All information is for educational and research purposes. Not medical advice. For research use only. Not for human consumption. Consult a qualified physician.